Vivalyx

Vivalyx

Developer of Omnisol, an investigational perfusion solution for preserving donor organs

vivalyx.com

Industry
Biotech, MedTech
Founded
2022
Based in
Germany

Verified revenue: not connected yet

Is Vivalyx yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.

Claim it if it’s yours

About

Vivalyx develops Omnisol, a blood-replacing perfusion solution designed to preserve and revitalise donor organs for transplantation. Omnisol is investigational and has entered first-in-human clinical use. The company is based in Aachen, Germany and is backed by Armenia-based Granatus Ventures.

Team

  • Andreas Schumacher, Co-founder and CEO (Founder)
  • Benedict Doorschodt, Co-founder and CTO (Founder)
  • René Tolba, Co-founder and CMO (Founder)
  • Christian Bleilevens, Co-founder and CSO (Founder)
  • Malte Brettel, Co-founder (Founder)
  • Marius Rosenberg, Co-founder (Founder)

Audience

Followers on social networks

Profile data from Stanbase.